Double blind trial of nicotinamide in recent-onset IDDM (the IMDIAB III study)

P. Pozzilli, N. Visalli, A. Signore, M. G. Baroni, R. Buzzetti, M. G. Cavallo, M. L. Boccuni, D. Fava, C. Gragnoli, D. Andreani, L. Lucentini, M. C. Matteoli, A. Crinò, C. A. Cicconetti, C. Teodonio, E. Paci, R. Amoretti, L. Pisano, M. G. Pennafina, G. SantopadreG. Marozzi, G. Multari, M. A. Suppa, L. Campea, G. C. De Mattia, M. Cassone Faldetta, G. Marietti, F. Perrone, A. V. Greco, G. Ghirlanda

Research output: Contribution to journalArticlepeer-review

75 Scopus citations

Fingerprint

Dive into the research topics of 'Double blind trial of nicotinamide in recent-onset IDDM (the IMDIAB III study)'. Together they form a unique fingerprint.

Medicine & Life Sciences